Internal Medicine, Nephrology · Wilmington, OH
NPI
1710911334
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
630 W Main St, Suite 209
Wilmington, OH, 45177
Phone (937) 383-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
1,831 services
Medicare patients, 2024
447
Average age 76
Drug cost, 2024
$424K
4,039 prescriptions
Company payments, 2025
$1,024
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Surmeet Bedi was code 99214 (office e&m - established), 900 times for 330 patients. In total Surmeet Bedi billed 1,831 services in 18 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 900 | 330 | $83.13 | $75K |
| 99213 Office E&M - Established | Office | 287 | 178 | $57.11 | $16K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 224 | 118 | $47.02 | $11K |
| 90960 ESRD Related Services (not dialysis) | Office | 122 | 17 | $265.95 | $32K |
| 99232 Hospital E&M - Subsequent | Facility | 94 | 30 | $59.50 | $5,593 |
| 99204 Office E&M - New | Office | 44 | 44 | $99.92 | $4,397 |
| 90961 ESRD Related Services (not dialysis) | Office | 25 | 11 | $220.80 | $5,520 |
| 99233 Hospital E&M - Subsequent | Facility | 15 | 14 | $89.73 | $1,346 |
By year: 2022 $188K for 1,753 services; 2023 $177K for 1,757 services; 2024 $168K for 1,831 services.
Medicare prescription drug claims, 2024
In 2024, the drug Surmeet Bedi prescribed most often to Medicare patients was Calcitriol, with 1,114 prescriptions and refills. In total Surmeet Bedi wrote 4,039 Medicare prescriptions that cost $424K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 1,114 | 3,011 | 319 | $23K |
| Allopurinol Generic | 420 | 1,150 | 125 | $3,979 |
| Potassium Chloride Generic | 307 | 779 | 103 | $7,048 |
| Furosemide Generic | 291 | 727 | 89 | $1,159 |
| Lisinopril Generic | 257 | 670 | 81 | $1,385 |
| Spironolactone Generic | 128 | 345 | 37 | $1,380 |
| Amlodipine Besylate Generic | 121 | 330 | 41 | $593 |
| Metolazone Generic | 113 | 235 | 37 | $3,459 |
| Torsemide Generic | 113 | 251 | 38 | $3,237 |
| Losartan Potassium Generic | 80 | 219 | 34 | $609 |
| Nifedipine Er Nifedipine | 65 | 169 | 15 | $1,436 |
| Sevelamer Carbonate Generic | 65 | 135 | 18 | $29K |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 60 | 155 | 21 | $320 |
| Hydralazine Hcl Generic | 57 | 137 | 18 | $794 |
| Hydrochlorothiazide Generic | 56 | 139 | 14 | $298 |
Brand drugs: 303 claims; generic drugs: 3,736 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Surmeet Bedi $1,024 ($1,024 in general payments such as food, travel and fees) from 12 companies. The largest payer was Calliditas Therapeutics US Inc. with $311.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 11 | $311 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $174 |
| Amgen Inc. AMGN | 5 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $83.29 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $78.48 |
| Ardelyx, Inc. ARDX | 4 | $77.07 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $46.15 |
| Kyowa Kirin, Inc. 4151.T | 3 | $44.74 |
| Fresenius USA Marketing, Inc. | 2 | $34.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.